Background: Impaired glucose regulation posttransplantation can affect allograft survival and may lead to the development of posttransplant diabetes mellitus (PTDM).

Objectives: The primary purpose of this study is to assess the difference in insulin burden between liver transplant patients who develop PTDM and patients who do not.

Methods: This was a single-center, retrospective study. Adult liver transplant recipients transplanted between January 1, 2005, and August 1, 2013, were included. PTDM was defined as: (1) use of an oral antihyperglycemic agent for ≥30 consecutive days after transplant, (2) use of insulin ≥30 consecutive days after transplant, or (3) hemoglobin A1C≥6.5 any time after transplant.

Results: Of the 114 patients included, 48 (42%) developed PTDM. The average 24-hour insulin requirement on the medical floors was 17.2 ± 14.5 units in the PTDM group and 11.3 ± 12.2 units in the PTDM-free group;P= 0.02. The average blood glucose level on the medical floor was 184.7 ± 31.5 mg/dL in the PTDM group and 169.3 ± 31.4 mg/dL in the PTDM-free group;P= 0.013. Multivariate analysis revealed that experiencing rejection was positively associated with the development of PTDM: adjusted odds ratio (AOR) = 3.237; 95% CI = 1.214-8.633. Basiliximab was negatively associated with the development of PTDM: AOR = 0.182; 95% CI = 0.040-0.836.

Conclusion: Univariate analyses suggest that insulin burden is a positive risk factor for the development of PTDM; this association is lost in multivariate analyses. Rejection was a positive predictor, and use of basiliximab was a negative predictor for the development of PTDM.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1060028015627662DOI Listing

Publication Analysis

Top Keywords

development ptdm
16
ptdm
9
diabetes mellitus
8
risk factor
8
insulin burden
8
liver transplant
8
≥30 consecutive
8
consecutive days
8
days transplant
8
ptdm group
8

Similar Publications

Posttransplant diabetes mellitus (PTDM) is associated with significant morbidity and mortality in liver transplant recipients (LTRs). We used the Organ Procurement and Transplantation Network (OPTN) database to compare the incidence of developing PTDM across the United States and develop a risk prediction model for new-onset PTDM using OPTN region as well as donor-related, recipient-related, and transplant-related factors. All US adult, primary, deceased donor, LTRs between January 1, 2007, and December 31, 2016, with no prior history of diabetes noted, were identified.

View Article and Find Full Text PDF

Influence of gut flora on diabetes management after kidney transplantation.

BMC Nephrol

December 2024

Department of Organ Transplantation, Affiliated Hospital of Guizhou Medical University, No. 28 Guimedical Street, Yunyan District, Guiyang, Guizhou Province, 550000, China.

Post-transplant diabetes mellitus (PTDM) is a common complication following renal transplantation, and its incidence has been gradually increasing in recent years, posing a significant public health challenge. Managing PTDM is complex, as studies suggest that it involves changes in the microbial flora across multiple organs. Recent research highlights the critical role of gut flora metabolism in the development of diabetes among post-renal transplant patients.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates changes in glycosylated hemoglobin (HbA1c) levels and the risk of post-transplant diabetes mellitus (PTDM) in kidney transplant recipients within the first year, focusing on demographic and health factors.
  • - Results show that 64.04% of the 203 kidney transplant recipients experienced clinically significant HbA1c changes, with pre-transplant diabetes patients showing the most notable increases; PTDM developed in 15.7% of nondiabetics.
  • - Key risk factors for significant HbA1c changes included increased age, weight change, and pre-existing hypertension, while PTDM was linked to older age and higher HbA1c levels at various checkpoints post-transplant
View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to determine the rate of post-transplant diabetes mellitus (PTDM) in prediabetic patients who received kidney transplants from living donors, while also analyzing the impact of hs-CRP levels and the TG/HDL-C ratio over three years.
  • - A total of 206 prediabetic patients were monitored, revealing that 29.6% developed PTDM, with measurements of BMI, plasma triglycerides, HDL-C, hs-CRP, and the TG/HDL-C ratio showing significant correlations to PTDM progression.
  • - The findings indicate that over one-third of the prediabetic patients developed PTDM following transplantation, with hs-CRP and the TG/HDL-C
View Article and Find Full Text PDF

Background: Post-transplant diabetes mellitus (PTDM) is a well-known complication of kidney transplantation that significantly impacts recipient morbidity and mortality. Over the recent years, the incidence of PTDM has increased considerably worldwide. Therefore, the primary purpose of this study was to evaluate the incidence and risk factors for PTDM in living donor kidney transplantation patients in Riyadh, Saudi Arabia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!